Intra-arterial Bevacizumab after Blood-brain Barrier Disruption for Refractory Radiation Necrosis

被引：0
|
作者：
Dashti, Shervin R.
Kadner, Robert
Folley, Bradley
Sheehan, Jason
Han, Dong
Kryscio, Richard
Carter, Mary
Plato, Brian
La Rocca, Renato
Spalding, Aaron
Yao, Tom
Fraser, Justin
机构：
来源：
JOURNAL OF NEUROSURGERY | 2021年 / 135卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
321
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [1] Intra-arterial bevacizumab after blood-brain barrier disruption for refractory radiation necrosis
    Dashti, S.
    Kadner, R.
    Folley, B.
    Sheehan, J.
    Han, D.
    Kryscio, R.
    Carter, M.
    Shields, L.
    Plato, B.
    La Rocca, R.
    Spalding, A.
    Yao, T.
    Fraser, J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S472 - S473
  • [2] Neurocognitive Improvement after Intra-Arterial Bevacizumab for Steroid-Refractory Radiation Necrosis of the Brain
    Folley, Bradley S.
    Kadner, Robert J.
    Sheehan, Jason P.
    Han, Dong Y.
    Kryscio, Richard J.
    Carter, Mary B.
    Shields, Lisa B. E.
    Plato, Brian M.
    La Rocca, Renato V.
    Spalding, Aaron C.
    Yao, Tom L.
    Fraser, Justin F.
    Dashti, Shervin R.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2021, 36 (06) : 1127 - 1128
  • [3] Disruption of the blood-brain barrier by intra-arterial administration of papaverine: a technical note
    Platz, Johannes
    Barath, Krisztina
    Keller, Emanuela
    Valavanis, Anton
    NEURORADIOLOGY, 2008, 50 (12) : 1035 - 1039
  • [4] Durability of single dose intra-arterial bevacizumab after blood/brain barrier disruption for recurrent glioblastoma
    Chakraborty, Shamik
    Filippi, Christopher G.
    Burkhardt, Jan-Karl
    Fralin, Sherese
    Ray, Ashley
    Wong, Tamika
    Ortiz, Rafael
    Langer, David J.
    Boockvar, John A.
    JOURNAL OF EXPERIMENTAL THERAPEUTICS AND ONCOLOGY, 2016, 11 (04) : 261 - 267
  • [5] Intra-arterial chemotherapy and osmotic blood-brain barrier disruption for primitive neuroectodermal tumors
    Jahnke, K.
    Kraemer, D. F.
    Fortin, D.
    Bell, S.
    Doolittle, N. D.
    Knight, K. R.
    Muldoon, L. L.
    Neuwelt, E. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Intra-Arterial Delivery of Bevacizumab after Blood-Brain Barrier Disruption for the Treatment of Recurrent Glioblastoma: Progression-Free Survival and Overall Survival
    Burkhardt, Jan-Karl
    Riina, Howard
    Shin, Benjamin J.
    Christos, Paul
    Kesavabhotla, Kartik
    Hofstetter, Christoph P.
    Tsiouris, Apostolos John
    Boockvar, John A.
    WORLD NEUROSURGERY, 2012, 77 (01) : 130 - 134
  • [7] Primary meningeal CNS lymphoma treated with intra-arterial chemotherapy and blood-brain barrier disruption
    Marcus W. C. MacNealy
    Herbert B. Newton
    John M. McGregor
    Susan D. Bell
    Abhik Ray Chaudhury
    H. Wayne Slone
    Eric C. Bourekas
    Journal of Neuro-Oncology, 2008, 90 : 329 - 333
  • [8] Enhanced chemotherapy delivery by intra-arterial infusion and blood-brain barrier disruption in cerebral metastasis
    Fortin, David
    Gendron, Cathy
    Boudrias, Marie
    NEURO-ONCOLOGY, 2006, 8 (04) : 442 - 442
  • [9] Primary meningeal CNS lymphoma treated with intra-arterial chemotherapy and blood-brain barrier disruption
    MacNealy, Marcus W. C.
    Newton, Herbert B.
    McGregor, John M.
    Bell, Susan D.
    Chaudhury, Abhik Ray
    Slone, H. Wayne
    Bourekas, Eric C.
    JOURNAL OF NEURO-ONCOLOGY, 2008, 90 (03) : 329 - 333
  • [10] Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors
    Uluc, Kutluay
    Ambady, Prakash
    McIntyre, Matthew K.
    Tabb, John Philip
    Kersch, Cymon N.
    Nerison, Caleb S.
    Huddleston, Amy
    Liu, Jesse J.
    Dogan, Aclan
    Priest, Ryan A.
    Fu, Rongwei
    Netto, Joao Prola
    Siler, Dominic A.
    Muldoon, Leslie L.
    Gahramanov, Seymur
    Neuwelt, Edward A.
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
12345